文献速递胰腺与胆道疾病

北美队列中早发型与晚发型特发性慢性胰腺炎的发病年龄及遗传变异影响差异

Differences in Age at Onset of Symptoms, and Effects of Genetic Variants, in Patients With Early vs Late-Onset Idiopathic Chronic Pancreatitis in a North American Cohort.
PubMed 文献 · Clin Gastroenterol Hepatol · 2020-03-30

该横断面分析基于北美胰腺炎研究2的1195例慢性胰腺炎患者,比较了终生戒酒的特发性慢性胰腺炎早发型与晚发型、轻中度饮酒慢性胰腺炎及酒精相关慢性胰腺炎的发病年龄与临床特征。早发型特发性患者中49%携带SPINK1、CFTR或CTRC致病性变异,高于晚发型(23%)和酒精相关(23%),且遗传变异影响部分亚组的发病年龄。

要点

  • 早发型特发性慢性胰腺炎中近半数携带SPINK1/CFTR/CTRC致病性变异,显著高于晚发型和酒精相关组。
  • 早发型患者持续疼痛比例(65%)高于晚发型(31%),而酒精相关组假性囊肿比例(43%)高于早发型(11%)。
  • SPINK1变异携带者中,早发型特发性患者发病中位年龄为12岁,轻中度饮酒者则为24岁。

核心结论

  • 在北美队列中确认了早发型与晚发型特发性慢性胰腺炎的发病年龄,并发现不同亚型临床特征存在差异。
  • 近半数早发型特发性慢性胰腺炎患者携带与慢性胰腺炎相关的遗传变异,而晚发型或酒精相关患者约为四分之一。
  • 遗传变异影响部分亚组的发病年龄。

研究设计与样本

  • 横断面分析,纳入北美胰腺炎研究2中1195例欧洲血统慢性胰腺炎患者,来自美国26个中心,2000年8月至2014年12月。
  • 比较130例终生戒酒的特发性慢性胰腺炎患者(早发型61例,晚发型69例)、308例轻中度饮酒慢性胰腺炎患者和225例重度饮酒酒精相关慢性胰腺炎患者。
  • 对可用患者DNA分析SPINK1、CFTR和CTRC中与慢性胰腺炎相关的变异,使用Kruskal-Wallis检验比较连续变量。

主要发现

  • 发病中位年龄:早发型特发性且无饮酒者20岁,晚发型特发性且无饮酒者58岁,轻中度饮酒慢性胰腺炎患者47岁,酒精相关慢性胰腺炎患者44岁。
  • 早发型特发性患者持续疼痛比例65%,高于晚发型31%(P = .04);酒精相关患者假性囊肿比例43%,高于早发型11%(P = .001)。
  • 早发型特发性患者中SPINK1、CFTR或CTRC致病性变异比例为49%,高于晚发型23%、轻中度饮酒慢性胰腺炎26%和酒精相关23%(P = .001)。
  • SPINK1变异携带者中,早发型特发性患者发病中位年龄12岁,轻中度饮酒慢性胰腺炎患者24岁。
  • CFTR变异携带者中,轻中度饮酒慢性胰腺炎患者发病中位年龄41岁,但该变异未影响早发型特发性或酒精相关患者的发病年龄。

临床怎么用

  • 对早发型特发性慢性胰腺炎患者应考虑进行SPINK1、CFTR和CTRC基因检测,因其遗传变异携带率较高。
  • 临床评估需注意早发型患者更易表现为持续疼痛,而酒精相关患者更易出现假性囊肿。
  • 遗传变异咨询应结合发病年龄和饮酒史,SPINK1变异携带者中早发型发病年龄更早。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Idiopathic chronic pancreatitis (ICP) is the second most common subtype of CP. In 1994, researchers reported the bimodal age at onset of ICP symptoms: early onset ICP (EO-ICP; median age, 19.2 y) and late-onset ICP (LO-ICP; median age, 56.2 y). Ages of onset and clinical features of ICP differed from those of alcohol-related CP (ACP). However, variants in PRSS1 had not yet been associated with ICP. We reexamined ages of onset of ICP in a large, North American cohort of patients, and investigated the effects of genetic factors and alcohol use in patients with EO-ICP, LO-ICP, and ACP. METHODS: We performed a cross-sectional analysis of patients with CP of European ancestry enrolled in the North American Pancreatitis Study 2, a prospective study of 1195 patients with CP from 26 centers in the United States from August 2000 through December 2014. We compared age at onset of symptoms for 130 patients with CP who were lifetime abstainers from alcohol (61 patients with early onset and 69 patients with late onset), 308 light to moderate alcohol drinkers with CP, and 225 patients with ACP and heavy to very heavy alcohol use. DNA from available patients was analyzed for variants associated with CP in SPINK1, CFTR, and CTRC. The Kruskal-Wallis test was used to compare continuous variables across groups and based on genetic variants. RESULTS: Median ages at onset of symptoms were 20 years for patients with EO-ICP and no alcohol use, 58 years for patients with LO-ICP and no alcohol use, 47 years for light to moderate alcohol drinkers with CP, and 44 years for patients with ACP. A higher proportion of patients with EO-ICP had constant pain (65%) than patients with LO-ICP (31%) (P = .04). A higher proportion of patients with ACP had pseudocysts (43%) than patients with EO-ICP (11%) (P = .001). A higher proportion of patients with EO-ICP had pathogenic variants in SPINK1, CFTR, or CTRC (49%) than patients with LO-ICP (23%), light to moderate alcohol drinking with CP (26%), or ACP (23%) (P = .001). Among patients with variants in SPINK1, those with EO-ICP had onset of symptoms at a median age of 12 years, and light to moderate alcohol drinkers with CP had an age at onset of 24 years. Among patients with variants in CFTR, light to moderate alcohol drinkers had an age at onset of symptoms of 41 years, but this variant did not affect age at onset of EO-ICP or ACP. CONCLUSIONS: We confirmed previously reported ages at onset of symptoms for EO-ICP and LO-ICP in a North American cohort. We found differences in clinical features among patients with EO-ICP, LO-ICP, and ACP. Almost half of patients with EO-ICP have genetic variants associated with CP, compared with approximately one quarter of patients with LO-CP or ACP. Genetic variants affect ages at onset of symptoms in some groups.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Lewis MD, Talluri J, Wilcox CM, et al. Differences in Age at Onset of Symptoms, and Effects of Genetic Variants, in Patients With Early vs Late-Onset Idiopathic Chronic Pancreatitis in a North American Cohort. Clin Gastroenterol Hepatol. 2020. PMID: 32240833. doi:10.1016/j.cgh.2020.03.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。